The prognosis of patients with MEN1-associated gastrinomas is associated with tumor size and the presence of hepatic metastases, with increased risk of hepatic metastases with increasing tumor size (103, 105). The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.